Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | ADH1B | P00325 | 2/20 | 0.38 |
| ▸ | ADH1C | P00326 | 2/20 | 0.38 |
| ▸ | ADH1A | P07327 | 2/20 | 0.38 |
| ▸ | ADH7 | P40394 | 2/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | S1PR2 | O95136 | 5/20 | 0.34 |
| ▸ | S1PR4 | O95977 | 5/20 | 0.34 |
| ▸ | S1PR1 | P21453 | 5/20 | 0.34 |
| ▸ | S1PR3 | Q99500 | 5/20 | 0.34 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.33 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15360400 | 0.98 | TSHR (0.48) | TSHRALDH1A1ADH1BADH1CADH1A | |
| SCHEMBL15360341 | 0.93 | TSHR (0.46) | TSHRALDH1A1ADH1BADH1CADH1A | |
| SCHEMBL614388 | 0.91 | TSHR (0.44) | TSHRALDH1A1ADH1BADH1AADH7 | |
| SCHEMBL28975742 | 0.91 | TSHR (0.39) | TSHRALDH1A1CYP2C19CYP1A2KMT2A | |
| SCHEMBL15004595 | 0.89 | TSHR (0.54) | TSHRALDH1A1ADH1BADH1CADH1A | |
| SCHEMBL555018 | 0.89 | TSHR (0.46) | TSHRALDH1A1ADH1BADH1CADH1A | |
| SCHEMBL27999229 | 0.89 | TSHR (0.46) | TSHRALDH1A1ADH1BADH1CADH1A | |
| Dimethylamine SCHEMBL18630929 | 0.88 | TSHR (0.41) | TSHRALDH1A1CYP2C19CYP1A2S1PR2 | |
| Hydrochloric Acid SCHEMBL6898636 | 0.88 | TSHR (0.52) | TSHRALDH1A1ADH1BADH1CADH1A | |
| SCHEMBL4326528 | 0.85 | TSHR (0.54) | TSHRALDH1A1ADH1BADH1CADH1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 177 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260042878-A1 | Curable Compositions Comprising At Least One Silane-Modified Polymer | HENKEL AG & CO KGAA (DE) | 2026-02-12 | — | — | US | claimed |
| EP-4562072-A1 | CROSS-LINKED ORGANOSILICON NETWORKS THAT DEGRADE WITH FLUORIDE SALTS | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2025-06-04 | — | — | EP | claimed |
| EP-4455178-A1 | CURABLE COMPOSITIONS COMPRISING AT LEAST ONE SILANE-MODIFIED POLYMER | Henkel AG & Co. KGaA (DE) | 2024-10-30 | — | — | EP | claimed |
| US-20240343942-A1 | CURABLE SILOXANE-MODIFIED RESIN COMPOSITIONS WITH SILICONE-OIL ADDITIVES AND USE THEREOF | THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY | 2024-10-17 | — | — | US | claimed |
| US-12018122-B2 | Method for producing silane-modified polymers | MERZ+BENTELI AG (CH) | 2024-06-25 | — | — | US | claimed |
| US-20240043601-A1 | CROSS-LINKED ORGANOSILICON NETWORKS THAT DEGRADE WITH FLUORIDE SALTS | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2024-02-08 | — | — | US | claimed |
| WO-2024026227-A1 | CROSS-LINKED ORGANOSILICON NETWORKS THAT DEGRADE WITH FLUORIDE SALTS | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2024-02-01 | — | — | WO | claimed |
| EP-3476876-B1 | PROCESS FOR THE PREPARATION OF SILYLATED POLYURETHANE POLYMERS USING TITANIUM-CONTAINING AND ZIRCONIUM-CONTAINING CATALYSTS | MOMENTIVE PERFORMANCE MAT INC (US) | 2023-08-09 | — | — | EP | claimed |
| EP-3877438-B1 | METHOD FOR THE PREPARATION OF SILANE-MODIFIED POLYMERS | MERZ BENTELI AG (CH) | 2023-06-14 | — | — | EP | claimed |
| CN-113166358-B | Process for preparing silane-modified polymers | 默兹奔特利股份公司 | 2023-03-28 | — | — | CN | claimed |
| US-20110319555-A1 | SINGLE-COMPONENT COATING HAVING ALKOXYSILANE-TERMINATED N-SUBSTITTUED UREA RESINS | SCIENCE APPLICATIONS INTERNATIONAL CORPORATION | 2011-12-29 | — | — | US | claimed |
| EP-1678267-B1 | COMPOSITION FOR PRODUCING A BARRIER LAYER FOR GASES | EVONIK DEGUSSA GMBH (DE) | 2011-12-21 | — | — | EP | claimed |
| EP-1718689-B1 | SILANE FORMULATION FOR MOISTURE-CROSSLINKING HYBRID ADHESIVES AND SEALANTS | EVONIK DEGUSSA GMBH (DE) | 2010-03-10 | — | — | EP | claimed |
| JP-2007513212-A | — | — | 2007-05-24 | — | — | JP | claimed |
| US-20070099004-A1 | Composition for producing a barrier layer for gases | DEGUSSA AG (DE) | 2007-05-03 | — | — | US | claimed |
| EP-1678267-A1 | COMPOSITION FOR PRODUCING A BARRIER LAYER FOR GASES | Degussa AG (DE) | 2006-07-12 | — | — | EP | claimed |
| EP-1245601-B1 | Metalfree silane terminated polyurethanes, a process for their preparation and their use | DEGUSSA (DE) | 2006-05-17 | — | — | EP | claimed |
| WO-2005040294-A1 | COMPOSITION FOR PRODUCING A BARRIER LAYER FOR GASES | DEGUSSA AG (DE) | 2005-05-06 | — | — | WO | claimed |
| US-6784272-B2 | REACTING AMINOALKYLALKOXYSILANE WITH A POLYURETHANE PREPOLYMER THAT HAS TERMINAL ISOCYANATE GROUP IN THE ABSENCE OF A METAL CATALYST | DEGUSSA AG (DE) | 2004-08-31 | — | — | US | claimed |
| US-20020188068-A1 | Metal-free silane-terminated polyurethanes, a process for their preparation and their use | DEGUSSA AG (DE) | 2002-12-12 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260042878-A1 | Curable Compositions Comprising At Least One Silane-Modified Polymer | CDH1, MECP2, COL14A1 | TSHR 4253/4885ALDH1A1 2682/4885ADH1B 4448/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.